Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04871750
Other study ID # SYW_01
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date June 15, 2021
Est. completion date June 2023

Study information

Verified date May 2021
Source Integrative Skin Science and Research
Contact Raja K Sivamani, MD
Phone (916) 524-1216
Email raja.sivamani@integrativeskinresearch.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Soy and soy-derived products are the primary dietary sources of isoflavones, particularly daidzein and genistein, for humans. Isoflavones are noted to have several effects on the skin including proliferation of keratinocytes resulting in epidermal thickening and increasing collagen and moisture content of the skin. Previous work has shown that the ingestion of an oral supplement containing soy isoflavones as a component led to a clinically measurable improvement in wrinkle depth after 14 weeks of supplementation. Ingestion of soy-based products has been shown to shift the Bifidobacteria and Lactobacilli among the gut microbiota and modulate the ratio of Firmicutes to Bacteroidetes. Many studies have shown that short-chain fatty acids result from beneficial shifts in the gut microbiome and may influence the inflammatory state of the skin. Therefore, the study aims to investigate whether soy-derived isoflavone can reduce wrinkles and alter both gut microbiome and short-chain fatty acids.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 80
Est. completion date June 2023
Est. primary completion date December 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 50 Years to 70 Years
Eligibility Inclusion Criteria: - Postmenopausal females, 50 to 70 years of age - Fitzpatrick skin type I or II, based on skin melanin content - BMI 18.5-35 kg/m2 - Must be willing to comply with all protocol requirements - Must be willing to have flash photo facial images taken with the imaging systems Exclusion Criteria: - Any systemic or antibiotics (injected or oral) within 6 months of starting study - Any topical antibiotic or benzoyl peroxide within 1 month of starting study or any subject unwilling to refrain from washout of topical antibacterial or benzoyl peroxide ingredient. - Allergic to soy and milk products - Fruit consumption > 2 cups/day - Vegetable consumption > 3 cups/day for females - Fruit juice consumption > 1 cup/day - Coffee consumption > 1 cup per day - Alcohol consumption = 3 servings per week (1 serving = 1 bottle of beer, ½ glass of wine, or 1 shot of hard liquor) - Self-reported malabsorption - Any oral probiotic or prebiotic supplementation within past 1 month at the discretion of the investigator. Probiotic and prebiotic containing foods are NOT considered an exclusion. - Subjects must have no history of malignancy or cancer or diagnosis of gastrointestinal inflammatory diseases, no history or diagnosis of epilepsy, no history or diagnosis of immunologic or infectious disease (e.g. hepatitis, tuberculosis, HIV or AIDS, lupus, rheumatoid arthritis) - Has a condition or is on medication the investigator and/or designee believe could jeopardize the safety of the subject, interfere with the evaluation, or confound the interpretation of the study results - Is participating in a concurrent intervention based clinical research study - Commencement of a new diet (such as the ketogenic diet) or supplements within the 1 month prior to initiating participation, at the discretion of the investigator. - Use of medications that alter blood lipids, such as statins and anti-hyperlipidemic medications - Is participating in or has participated in a intervention based facial study at this or any other facility in the past 2 weeks. Participation in survey-based studies are approved at the discretion of the investigator. - Has a skin disease on face that will interfere with image collection and assessment in the opinion of the investigator - Persons unwilling to avoid the following during the 4 weeks prior and during the duration of the study: self-tanning, spa tanning, sun tanning, or artificial tanning. - Planned vacation to sunny destination with the intention of sun tanning during the duration of the study. - Persons who regularly undergo sauna treatments (dry or wet) or who swim daily. Known allergy or irritation to the supplement or facial products utilized in the study - Current tobacco smokers, OR those that have smoked tobacco over the past year, OR a 5 year-pack year history of smoking tobacco - Prisoners - Adults unable to consent - Vegans and vegetarians

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Soy protein
Daily consumption for 24 weeks
Casein protein
Daily consumption for 24 weeks

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Integrative Skin Science and Research United Soybean Board

Outcome

Type Measure Description Time frame Safety issue
Primary Facial wrinkles Wrinkle severity score measured by Facial Image Analysis System week 24
Secondary Procollagen I expression Assess with biopsy (optional participation) 24
Secondary Pigment intensity score Measured by the 3D Clarity Pro® Facial Modeling and Analysis System (Brigh-Tex BioPhotonics, San Jose, CA) week 24
Secondary Blood levels of soy isoflavones and metabolites Blood samples will be collected week 24
Secondary Gut microbiome Evaluate changes in the gut microbiome (Bifidobacteria and Lactobacilli, ratio of Firmicutes to Bacteroidetes) through stool samples week 24
Secondary Blood lipidome Assess changes in butyrate, propionate, and acetate levels week 24
Secondary Facial wrinkles Wrinkle score measured by Facial Image Analysis System week 8
Secondary Facial wrinkles Wrinkle score measured by Facial Image Analysis System week 16
See also
  Status Clinical Trial Phase
Completed NCT05271136 - A Clinical Study to Evaluate the Efficacy of an Anti-Aging Serum N/A
Completed NCT05514782 - A Clinical Study to Evaluate the Long-Term Efficacy and Tolerability of a Daily Anti-Aging Daily Serum N/A
Completed NCT04911374 - An Open-Label Clinical Study to Evaluate the Efficacy of a Face Cream and Eye Cream N/A
Completed NCT04586816 - Randomized, Double-Blind Evaluation of Maple Leaf Extract (Maplifa) for Photoaging N/A
Completed NCT05039723 - Xeomin, Radiesse, and Belotero Facial/Neck Rejuvenational Phase 4
Not yet recruiting NCT05004909 - Effectivity of 1 Finger Tip Unit Compared to 2 Finger Tip Units 0.05% Tretinoin Cream N/A
Completed NCT06366503 - Evaluating Procedure Pairing of a Post-Procedure Cream Versus a Comparator in Patients Treated With Fractional Ablative CO2 Laser for Facial Rejuvenation N/A
Completed NCT05027282 - Safety and Effectiveness of the CLEAR + BRILLIANT TOUCH(R) Diode Laser 1440-nm and 1927-nm Combination Wavelength Treatment N/A
Not yet recruiting NCT06096649 - The Effects of Zinc Di-(Dibutyryl Lisinate) on Skin Health and the Skin Microbiome in Photoaged Skin N/A
Completed NCT03661697 - Combination Versus Laser Treatment Only N/A
Completed NCT03948945 - Efficacy and Safety of Profile HaloTM Mixed Fractional Laser on Treating of Facial and Neck Photoaging. N/A
Completed NCT06148558 - A Twelve Week Clinical Study to Evaluate the Efficacy and Tolerability of a Sunscreen Moisturizer SPF 50+ N/A
Enrolling by invitation NCT06188338 - A 56-day Clinical Study on Facial Skin Rejuvenation N/A
Recruiting NCT06195605 - Investigating Age Dependence of Fibroblast and Extracellular Matrix Responses to Cross-linked Hyaluronic Acid Filler in Human Skin N/A
Not yet recruiting NCT04869852 - Effects of Mango Intake on Skin Health and Gut Microbiome Changes in Postmenopausal Women N/A
Not yet recruiting NCT02126644 - The Efficacy and Safety of a Single 70% Glycolic Acid Peel With Vitamin C for the Treatment of Photoaging Phase 2
Active, not recruiting NCT01372566 - Effect of Platelet Rich Plasma on Photoaged Skin Phase 1/Phase 2
Unknown status NCT00842907 - Efficacy and Safety of Oral Isotretinoin for Cutaneous Photodamage Phase 2
Completed NCT03112863 - Comparison of the Cosmetic Effects of Bakuchiol and Retinol Early Phase 1
Recruiting NCT05386368 - RECELL to Promote Healing Following Carbon Dioxide (CO2) Laser Treatment in Cosmetic Patients Phase 4